AG
KYNB

Algert Global’s Kyntra Bio KYNB Stock Holding History

Algert Global’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,462
Closed -$139K – 1168
2023
Q3 		$139K Buy
6,462
+5,364
+489% +$211K 0.01% 1004
2023
Q2 		$74K Buy
+1,098
New +$454K ﹤0.01% 1046
2022
Q4 		– Sell
-1,010
Closed -$329K – 1170
2022
Q3 		$329K Sell
1,010
-448
-31% -$144K 0.02% 928
2022
Q2 		$385K Buy
+1,458
New +$373K 0.03% 845
2017
Q2 		– Sell
-973
Closed -$600K – 316
2017
Q1 		$600K Buy
973
+59
+6% +$35.9K 0.16% 213
2016
Q4 		$489K Buy
+914
New +$456K 0.14% 233

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Algert Global's KYNB Position: Q4 2023 in Review

Algert Global sold out of Kyntra Bio (KYNB) in Q4 2023, closing a stake of 6,462 shares — an estimated $139K sold.

Algert Global first reported a position in KYNB in Q4 2016 and held it in 6 quarters. The position peaked at $600K in Q1 2017. 100 funds tracked by Wall St. Rank hold KYNB as of Q4 2023.

  • Algert Global reported no remaining Kyntra Bio position as of Q4 2023 after selling out during the quarter.
  • Algert Global sold 6,462 Kyntra Bio shares in Q4 2023, an estimated $139K.
  • Algert Global first reported a position in Kyntra Bio in Q4 2016 and held it in 6 quarters.
  • Algert Global's Kyntra Bio position peaked at $600K in Q1 2017.
  • 100 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2023.

Based on Algert Global's 13F filing for Q4 2023, filed 14 Feb 2024.